PCL Viability

Wikis > PCL Viability

Thermoplastics in bioprinting are often used as a support structure to provide extra mechanical strength and as reinforcement for matrix bioinks[1,2]. Polycaprolactone is a biodegradable thermoplastic used in a variety of medical applications, including bioprinting. This study tested the viability and print resolution of  polycaprolactone, or PCL, with the BioBot 1.

PCL Print Resolution

PCL updatedFigure 1: Images of printed lattice structures demonstrate reproducibility and high resolution. Left: image of printed lattice structure. Right: Brightfield image of printed lattice at 4x magnification (scale bar 0.5 mm).

PCL was printed using print parameters and settings provided by BioBots (Figure 1). Line width and pore size were analyzed with ImageJ software. Five measurements were taken of 3 separate prints of the same design (Figure 2). Pore width average was 140 ± 38 μm, while line width average was 150 ± 38 μm.

PCL Viability

Cell Culture

Primary Human Neonatal Dermal Fibroblasts (HNDFs) from ATCC were cultured at 37 °C and 5% of CO2. HNDFs were cultured using Dulbecco’s Modified Eagle Medium (Corning) supplemented with 10% fetal bovine serum (Hyclone) and 1% penicillin-streptomycin-amphotericin (Corning). Passage numbers under 10 were used.

Thin Film Fabrication

Viability of BioPCL was tested with cell seeding of human neonatal dermal fibroblasts. First, PCL was sterilized through an overnight wash in 100% ethanol. Then, thin films were fabricated by melting 0.023 g of PCL  at 90°C on a glass coverslip, then flattening with a second glass coverslip. Thin films were then allowed to cool to room temperature before removal from coverslips. Films were then cut to fit into 96 well plates.

HNDFs were suspended at a concentration of 250,000 cells mL-1 and pipetted into the wells containing the PCL thin films. Enough cell solution was used to submerge the samples. After overnight incubation, media was exchanged. Films were suspended in a cell concentration of 250,000 cells/ml.

Viability Assessment

To quantitatively assess cell viability, PrestoBlue Assay (Promega) was performed on days 1,3 and 7 of culture according to manufacturer’s protocol and analyzed using a BioTek Synergy 2 Plate Reader.

Statistical analysis was performed using an Analysis of Variance (ANOVA) test to determine if differences were present amongst treatment groups. If differences were determined from the ANOVA, a post hoc Tukey’s multiple comparison test was used to determine statistical differences between groups tested. A confidence level of 95% (α=0.05) was used for all analyses. Error bars on graphs represent the standard deviation from the mean.

Results

BioPCL viability

Figure 3: PrestoBlue Viability results demonstrate that BioPCL is able to support viable cell cultures. Viability was measured via a PrestoBlue assay on days 1,3 and 7 of culture with human neonatal dermal fibroblasts. Viability is normalized to 2D culture control.

To determine viability of cells seeded on PCL, a PrestoBlue assay was used to quantitatively measure and compare viability to a 2D culture control. When compared to 2D controls, no significant differences were found at Day 1,3 or 7 time points (P> 0.05). Figure 3 depicts viability results for thin films normalized to 2D control.

These results demonstrate the ability of PCL to support viable cultures and create consistent, high resolution 3D geometries. This support material can be used in combination with matrix bioinks or on its own to create 3D culture environments for tissue engineering.

References

[1]
J. Kundu and e. al, “An Additive Manufacturing-Based PCL-Alginate-Chondrocyte Bioprinted Scaffold for Cartilage Tissue Engineering,Tissue Engineering: Part B, vol. 14, no. 2, 2008.
[2]